Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders

L. Yan, A. Shamir, M. Skirzewski, E. Leiva-Salcedo, O. B. Kwon, I. Karavanova, D. Paredes, O. Malkesman, K. R. Bailey, D. Vullhorst, Jacqueline Crawley, A. Buonanno

Research output: Contribution to journalArticle

11 Citations (Scopus)

Abstract

Numerous genetic and functional studies implicate variants of Neuregulin-1 (NRG1) and its neuronal receptor ErbB4 in schizophrenia and many of its endophenotypes. Although the neurophysiological and behavioral phenotypes of NRG1 mutant mice have been investigated extensively, practically nothing is known about the function of NRG2, the closest NRG1 homolog. We found that NRG2 expression in the adult rodent brain does not overlap with NRG1 and is more extensive than originally reported, including expression in the striatum and medial prefrontal cortex (mPFC), and therefore generated NRG2 knockout mice (KO) to study its function. NRG2 KOs have higher extracellular dopamine levels in the dorsal striatum but lower levels in the mPFC; a pattern with similarities to dopamine dysbalance in schizophrenia. Like ErbB4 KO mice, NRG2 KOs performed abnormally in a battery of behavioral tasks relevant to psychiatric disorders. NRG2 KOs exhibit hyperactivity in a novelty-induced open field, deficits in prepulse inhibition, hypersensitivity to amphetamine, antisocial behaviors, reduced anxiety-like behavior in the elevated plus maze and deficits in the T-maze alteration reward test—a task dependent on hippocampal and mPFC function. Acute administration of clozapine rapidly increased extracellular dopamine levels in the mPFC and improved alternation T-maze performance. Similar to mice treated chronically with N-methyl-d-aspartate receptor (NMDAR) antagonists, we demonstrate that NMDAR synaptic currents in NRG2 KOs are augmented at hippocampal glutamatergic synapses and are more sensitive to ifenprodil, indicating an increased contribution of GluN2B-containing NMDARs. Our findings reveal a novel role for NRG2 in the modulation of behaviors with relevance to psychiatric disorders.Molecular Psychiatry advance online publication, 21 March 2017; doi:10.1038/mp.2017.22.

Original languageEnglish (US)
JournalMolecular Psychiatry
DOIs
StateAccepted/In press - Mar 21 2017

Fingerprint

Neuregulins
Neuregulin-1
Prefrontal Cortex
Psychiatry
Dopamine
Phenotype
Knockout Mice
Schizophrenia
Endophenotypes
Clozapine
Amphetamine
Reward
Synapses
Publications
Rodentia
Hypersensitivity
Anxiety
Brain

ASJC Scopus subject areas

  • Molecular Biology
  • Cellular and Molecular Neuroscience
  • Psychiatry and Mental health

Cite this

Yan, L., Shamir, A., Skirzewski, M., Leiva-Salcedo, E., Kwon, O. B., Karavanova, I., ... Buonanno, A. (Accepted/In press). Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders. Molecular Psychiatry. https://doi.org/10.1038/mp.2017.22

Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders. / Yan, L.; Shamir, A.; Skirzewski, M.; Leiva-Salcedo, E.; Kwon, O. B.; Karavanova, I.; Paredes, D.; Malkesman, O.; Bailey, K. R.; Vullhorst, D.; Crawley, Jacqueline; Buonanno, A.

In: Molecular Psychiatry, 21.03.2017.

Research output: Contribution to journalArticle

Yan, L, Shamir, A, Skirzewski, M, Leiva-Salcedo, E, Kwon, OB, Karavanova, I, Paredes, D, Malkesman, O, Bailey, KR, Vullhorst, D, Crawley, J & Buonanno, A 2017, 'Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders', Molecular Psychiatry. https://doi.org/10.1038/mp.2017.22
Yan, L. ; Shamir, A. ; Skirzewski, M. ; Leiva-Salcedo, E. ; Kwon, O. B. ; Karavanova, I. ; Paredes, D. ; Malkesman, O. ; Bailey, K. R. ; Vullhorst, D. ; Crawley, Jacqueline ; Buonanno, A. / Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders. In: Molecular Psychiatry. 2017.
@article{90607fa990d84fc78ffcbd01c67d52b2,
title = "Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders",
abstract = "Numerous genetic and functional studies implicate variants of Neuregulin-1 (NRG1) and its neuronal receptor ErbB4 in schizophrenia and many of its endophenotypes. Although the neurophysiological and behavioral phenotypes of NRG1 mutant mice have been investigated extensively, practically nothing is known about the function of NRG2, the closest NRG1 homolog. We found that NRG2 expression in the adult rodent brain does not overlap with NRG1 and is more extensive than originally reported, including expression in the striatum and medial prefrontal cortex (mPFC), and therefore generated NRG2 knockout mice (KO) to study its function. NRG2 KOs have higher extracellular dopamine levels in the dorsal striatum but lower levels in the mPFC; a pattern with similarities to dopamine dysbalance in schizophrenia. Like ErbB4 KO mice, NRG2 KOs performed abnormally in a battery of behavioral tasks relevant to psychiatric disorders. NRG2 KOs exhibit hyperactivity in a novelty-induced open field, deficits in prepulse inhibition, hypersensitivity to amphetamine, antisocial behaviors, reduced anxiety-like behavior in the elevated plus maze and deficits in the T-maze alteration reward test—a task dependent on hippocampal and mPFC function. Acute administration of clozapine rapidly increased extracellular dopamine levels in the mPFC and improved alternation T-maze performance. Similar to mice treated chronically with N-methyl-d-aspartate receptor (NMDAR) antagonists, we demonstrate that NMDAR synaptic currents in NRG2 KOs are augmented at hippocampal glutamatergic synapses and are more sensitive to ifenprodil, indicating an increased contribution of GluN2B-containing NMDARs. Our findings reveal a novel role for NRG2 in the modulation of behaviors with relevance to psychiatric disorders.Molecular Psychiatry advance online publication, 21 March 2017; doi:10.1038/mp.2017.22.",
author = "L. Yan and A. Shamir and M. Skirzewski and E. Leiva-Salcedo and Kwon, {O. B.} and I. Karavanova and D. Paredes and O. Malkesman and Bailey, {K. R.} and D. Vullhorst and Jacqueline Crawley and A. Buonanno",
year = "2017",
month = "3",
day = "21",
doi = "10.1038/mp.2017.22",
language = "English (US)",
journal = "Molecular Psychiatry",
issn = "1359-4184",
publisher = "Nature Publishing Group",

}

TY - JOUR

T1 - Neuregulin-2 ablation results in dopamine dysregulation and severe behavioral phenotypes relevant to psychiatric disorders

AU - Yan, L.

AU - Shamir, A.

AU - Skirzewski, M.

AU - Leiva-Salcedo, E.

AU - Kwon, O. B.

AU - Karavanova, I.

AU - Paredes, D.

AU - Malkesman, O.

AU - Bailey, K. R.

AU - Vullhorst, D.

AU - Crawley, Jacqueline

AU - Buonanno, A.

PY - 2017/3/21

Y1 - 2017/3/21

N2 - Numerous genetic and functional studies implicate variants of Neuregulin-1 (NRG1) and its neuronal receptor ErbB4 in schizophrenia and many of its endophenotypes. Although the neurophysiological and behavioral phenotypes of NRG1 mutant mice have been investigated extensively, practically nothing is known about the function of NRG2, the closest NRG1 homolog. We found that NRG2 expression in the adult rodent brain does not overlap with NRG1 and is more extensive than originally reported, including expression in the striatum and medial prefrontal cortex (mPFC), and therefore generated NRG2 knockout mice (KO) to study its function. NRG2 KOs have higher extracellular dopamine levels in the dorsal striatum but lower levels in the mPFC; a pattern with similarities to dopamine dysbalance in schizophrenia. Like ErbB4 KO mice, NRG2 KOs performed abnormally in a battery of behavioral tasks relevant to psychiatric disorders. NRG2 KOs exhibit hyperactivity in a novelty-induced open field, deficits in prepulse inhibition, hypersensitivity to amphetamine, antisocial behaviors, reduced anxiety-like behavior in the elevated plus maze and deficits in the T-maze alteration reward test—a task dependent on hippocampal and mPFC function. Acute administration of clozapine rapidly increased extracellular dopamine levels in the mPFC and improved alternation T-maze performance. Similar to mice treated chronically with N-methyl-d-aspartate receptor (NMDAR) antagonists, we demonstrate that NMDAR synaptic currents in NRG2 KOs are augmented at hippocampal glutamatergic synapses and are more sensitive to ifenprodil, indicating an increased contribution of GluN2B-containing NMDARs. Our findings reveal a novel role for NRG2 in the modulation of behaviors with relevance to psychiatric disorders.Molecular Psychiatry advance online publication, 21 March 2017; doi:10.1038/mp.2017.22.

AB - Numerous genetic and functional studies implicate variants of Neuregulin-1 (NRG1) and its neuronal receptor ErbB4 in schizophrenia and many of its endophenotypes. Although the neurophysiological and behavioral phenotypes of NRG1 mutant mice have been investigated extensively, practically nothing is known about the function of NRG2, the closest NRG1 homolog. We found that NRG2 expression in the adult rodent brain does not overlap with NRG1 and is more extensive than originally reported, including expression in the striatum and medial prefrontal cortex (mPFC), and therefore generated NRG2 knockout mice (KO) to study its function. NRG2 KOs have higher extracellular dopamine levels in the dorsal striatum but lower levels in the mPFC; a pattern with similarities to dopamine dysbalance in schizophrenia. Like ErbB4 KO mice, NRG2 KOs performed abnormally in a battery of behavioral tasks relevant to psychiatric disorders. NRG2 KOs exhibit hyperactivity in a novelty-induced open field, deficits in prepulse inhibition, hypersensitivity to amphetamine, antisocial behaviors, reduced anxiety-like behavior in the elevated plus maze and deficits in the T-maze alteration reward test—a task dependent on hippocampal and mPFC function. Acute administration of clozapine rapidly increased extracellular dopamine levels in the mPFC and improved alternation T-maze performance. Similar to mice treated chronically with N-methyl-d-aspartate receptor (NMDAR) antagonists, we demonstrate that NMDAR synaptic currents in NRG2 KOs are augmented at hippocampal glutamatergic synapses and are more sensitive to ifenprodil, indicating an increased contribution of GluN2B-containing NMDARs. Our findings reveal a novel role for NRG2 in the modulation of behaviors with relevance to psychiatric disorders.Molecular Psychiatry advance online publication, 21 March 2017; doi:10.1038/mp.2017.22.

UR - http://www.scopus.com/inward/record.url?scp=85015694962&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85015694962&partnerID=8YFLogxK

U2 - 10.1038/mp.2017.22

DO - 10.1038/mp.2017.22

M3 - Article

C2 - 28322273

AN - SCOPUS:85015694962

JO - Molecular Psychiatry

JF - Molecular Psychiatry

SN - 1359-4184

ER -